- Home
- UNCY vs FLL Comparison
UNCY vs FLL Comparison
Compare UNCY & FLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNCY | FLL |
|---|---|---|
| Founded | 2016 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.9M | 108.7M |
| IPO Year | 2021 | 1993 |
Fundamental Metrics
Financial Performance| Metric | UNCY | FLL |
|---|---|---|
| Price | $6.06 | $2.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $44.50 | $5.00 |
| AVG Volume (30 Days) | ★ 451.4K | 188.9K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $299,916,000.00 |
| Revenue This Year | N/A | $4.96 |
| Revenue Next Year | $19,392.60 | $8.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.45 |
| 52 Week Low | $3.71 | $2.25 |
| 52 Week High | $11.00 | $5.59 |
Technical Indicators
Market Signals| Indicator | UNCY | FLL |
|---|---|---|
| Relative Strength Index (RSI) | 61.73 | 62.69 |
| Support Level | $5.96 | $2.62 |
| Resistance Level | $6.70 | $2.74 |
| Average True Range (ATR) | 0.46 | 0.16 |
| MACD | 0.06 | 0.06 |
| Stochastic Oscillator | 63.68 | 95.24 |
Price Performance
Historical ComparisonAbout UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About FLL Full House Resorts Inc.
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.